Pharmabiz36m
Kynos Therapeutics announces top-line results from phase I study of its KMO inhibitor, KNS366; shows safety and tolerability
Kynos Therapeutics announces top-line results from phase I study of its KMO inhibitor, KNS366; shows safety and tolerability: Edinburgh Tuesday, April 23, 2024, 14:00 Hrs [IST] Ky ...
Pharmabiz1h
Industry and trade leaders in Telangana offer full support to DCA for strong actions against illegal activities
Pharmaceutical industry and trade leaders in Telangana have offered full support to the state drugs control administration (DCA) for its stringent actions against illegal and unethical business ...
Pharmabiz1h
NeuroSmart Portable MER system paves way for improved treatments in Parkinson’s disease
Positive outcomes with brain pacemakers & NeuroSmart Portable MER (micro-electrode recording) system have paved the way for improved treatments in Parkinson’s disease. The advanced technology ...
Pharmabiz1h
BioArctic, Eisai ink research evaluation agreement regarding BAN2802
BioArctic, Eisai ink research evaluation agreement regarding BAN2802: Stockholm, Sweden Tuesday, April 23, 2024, 13:00 Hrs [IST] BioArctic AB (publ), a Swedish research-based biop ...
Pharmabiz2h
Immunovia’s model-development study of next-generation pancreatic cancer detection test achieves primary and secondary endpoints
Immunovia’s model-development study of next-generation pancreatic cancer detection test achieves primary and secondary endpoints: Lund, Sweden Tuesday, April 23, 2024, 12:00 Hrs ...
Pharmabiz3h
TAVR in a morbidly obese patient with critical aortic stenosis conducted at Lilavati Hospital, Mumbai
TAVR in a morbidly obese patient with critical aortic stenosis conducted at Lilavati Hospital, Mumbai: Our Bureau, Mumbai Tuesday, April 23, 2024, 11:15 Hrs [IST] A Transcatheter ...
Pharmabiz3h
HP boosts Make in India with its technology Indo-MIM to mass produce metal 3D printer parts in healthcare, among others
HP boosts Make in India with its technology Indo-MIM to mass produce metal 3D printer parts in healthcare, among others: Our Bureau, Bengaluru Tuesday, April 23, 2024, 11:00 Hrs [ ...
Pharmabiz4h
Bristol Myers Squibb, Cellares announce a $380 mn worldwide capacity reservation and supply agreement for manufacture of CAR T cell therapies
Princeton, New Jersey Tuesday, April 23, 2024, 10:00 Hrs [IST] ...
Pharmabiz5h
Takeda, Astellas & Sumitomo Mitsui Banking enter master agreement to establish JV company for incubation of early drug discovery programmes
Takeda, Astellas & Sumitomo Mitsui Banking enter master agreement to establish JV company for incubation of early drug discovery programmes: Tokyo, Japan Tuesday, April 23, 2024, ...
Pharmabiz6h
Pharma companies need to explore various pricing strategies for optimum utilisation of patent-cliff: DoP study
Gireesh Babu, New Delhi Tuesday, April 23, 2024, 08:00 Hrs [IST] ...
Pharmabiz6h
NABH unveils plan for 2nd Edition of Accreditation Standards for Allopathic Clinics
In a significant development for healthcare quality assurance in India, the National Accreditation Board for Hospitals & ...
Pharmabiz6h
DCC recommends SLAs to take action and submit report to CDSCO on AMR
DCC recommends SLAs to take action and submit report to CDSCO on AMR: Gireesh Babu, New Delhi Tuesday, April 23, 2024, 08:00 Hrs [IST] The Drugs Consultative Committee (DCC) has r ...